Acute Lymphoblastic Leukemia
Biojam has established itself as a leader in the Iberian market in the development and provision of therapeutic solutions for Acute Lymphoblastic Leukemia, a disease that primarily affects children and young adults.
In collaboration with its R&D and manufacturing partners, Biojam has been committed to innovation, particularly in the development of delivery methods tailored to patients’ specific needs.
Traditionally, many therapies have been developed with the adult population in mind, and they do not always adequately meet the needs of pediatric patients. In this context, research has focused on creating solutions that allow for more precise dosing, tailored to each patient’s body weight and individual characteristics.
This commitment also extends to other types of cancer, where personalized therapy is essential. The goal is to provide effective and easy-to-administer alternatives, especially in situations where conventional oral solid dosage forms are not suitable.
Through this approach, Biojam contributes to a more precise, accessible, and patient-centered approach to medicine.
Organ Preservation
Biojam operates in the field of organ preservation for transplantation and cardioplegia as the exclusive representative of the Servator brand in Portugal, Spain, the Benelux countries, Cape Verde, and Brazil.
In a highly demanding clinical setting, where time and the quality of processes are critical, Servator’s solutions stand out for their scientific rigor, safety, and reliability, contributing to the optimization of organ preservation and transport conditions.
Proper preservation is a critical factor for the success of transplants, directly influencing organ viability and clinical outcomes. In this regard, Biojam ensures access to advanced technologies that meet the needs of healthcare professionals and transplant teams.
At the same time, in the field of cardioplegia, the solutions provided enable effective protection of the heart muscle during surgical procedures, underscoring the importance of innovative and safe approaches in highly complex settings.
With strong ties to clinical practice and scientific advancements, Biojam positions itself as a trusted partner, contributing to the continuous improvement of healthcare.
For more information, visit Servator.pt.
